Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine2B receptor agonists: Implications for drug safety assessment
- Xi Ping Huang
- , Vincent Setola
- , Prem N. Yadav
- , John A. Allen
- , Sarah C. Rogan
- , Bonnie J. Hanson
- , Chetana Revankar
- , Matt Robers
- , Chris Doucette
- , Bryan L. Roth
Research output: Contribution to journal › Article › peer-review
134
Link opens in a new tab
Scopus
citations